Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 880

1.

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.

Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH.

J Hypertens. 2006 Nov;24(11):2131-41. Review.

PMID:
17053529
2.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
3.

Beta-blockers for hypertension.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH.

Cochrane Database Syst Rev. 2017 Jan 20;1:CD002003. doi: 10.1002/14651858.CD002003.pub5. Review.

4.

Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.

Opie LH, Schall R.

J Am Coll Cardiol. 2002 Jan 16;39(2):315-22. Erratum in: J Am Coll Cardiol 2002 Apr 17;39(8):1409-10.

5.

Beta-blockers for hypertension.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002003. doi: 10.1002/14651858.CD002003.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002003.

PMID:
22895924
6.

Beta-blockers for hypertension.

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002003. doi: 10.1002/14651858.CD002003.pub4. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 20;1:CD002003.

PMID:
23152211
7.

Systematic review: antihypertensive drug therapy in black patients.

Brewster LM, van Montfrans GA, Kleijnen J.

Ann Intern Med. 2004 Oct 19;141(8):614-27. Review.

PMID:
15492341
8.

Clinical efficacies of antihypertensive drugs.

Aursnes I, Tvete IF, Gåsemyr J, Natvig B.

Scand Cardiovasc J. 2003 May;37(2):72-9.

PMID:
12775305
9.

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

Kuti EL, Baker WL, White CM.

Curr Med Res Opin. 2007 Jun;23(6):1239-44. Epub 2007 Apr 23.

PMID:
17559720
10.

Are there benefits to specific antihypertensive drug therapy?

Cushman WC.

Am J Hypertens. 2003 Nov;16(11 Pt 2):31S-35S. Review.

PMID:
14625158
11.

Calcium channel blockers versus other classes of drugs for hypertension.

Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, Wang Y, Yang X, He L.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD003654. doi: 10.1002/14651858.CD003654.pub4. Review.

PMID:
20687074
12.

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.

Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GW, Wright JM.

Cochrane Database Syst Rev. 2015 Jan 11;1:CD008170. doi: 10.1002/14651858.CD008170.pub2. Review.

PMID:
25577154
13.

Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?

Wink K.

Curr Hypertens Rep. 2003 Jun;5(3):221-4. Review.

PMID:
12724054
14.
15.

Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis.

Van Bortel LM, Fici F, Mascagni F.

Am J Cardiovasc Drugs. 2008;8(1):35-44.

PMID:
18303936
16.

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.

JAMA. 2003 May 21;289(19):2534-44.

PMID:
12759325
17.

Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?

Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.

Blood Press. 2007;16(1):6-12.

PMID:
17453746
18.

Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.

Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G.

Eur Heart J. 2009 Mar;30(6):679-88. doi: 10.1093/eurheartj/ehn575. Epub 2009 Jan 23.

PMID:
19168534
19.
20.

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

Can J Cardiol. 2004 Jan;20(1):41-54.

PMID:
14968142

Supplemental Content

Support Center